Spotting A Winner: Bristol-Myers Squibb Co. (NYSE: BMY) Advances 1.37 And It Still Have Room To Run

Bristol-Myers Squibb Co. (NYSE:BMY) currently has a daily average trading volume of 15.98M but it saw 22028543 shares traded in last market. With a market cap of 91.77B USD, the company’s current market price of $45.27 came rising about 1.37 while comparing to the previous closing price of $44.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $64.65 and as low as $39.35.

Taking a look at 20-day trading activity of Bristol-Myers Squibb Co. (BMY) gives us an average price of $41.64, while its current price level is -29.98% below from 52-week high level whereas it is 15.04% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $41.85 while that of 200 days or SMA-200 reads an average of $48.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.81% during that period while stretching the period over a month that decreases to 2.64%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 69.78 which implies that the stock is in neutral territory.

Redburn Atlantic downgraded its recommendation for the stock as a “Neutral” from “Buy” on February 06, 2024 while assigning a price target range of $77-$54. BofA Securities also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $68 and $60.

Over the week, BMY’s stock price is moving 6.79% up while it is 7.30% when we observe its performance for the past one month. Year-to-date it is -11.77% down and over the past year, the stock is showing a downside performance of -29.01%.

Currently, Bristol-Myers Squibb Co.’s total number of outstanding shares is 2.03B. Company’s return on investment (ROI) stands at -9.10% and return on equity (ROE) at -25.45%. It has a 6.62 of forward P/E ratio. Stock’s beta reads 0.43. Stock has a price to book (P/B) ratio of 5.56 while price to sale or P/S ratio amounts to 2.02. Its return on asset (ROA) is -6.36% on average.